Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Synbiotic Therapy in Infantile Colic Resistant to Conservative Therapy: A Clinical Trial Publisher



Taheri PA1 ; Rostami S2 ; Eftekhari K3 ; Danesh S4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neonatology, Tehran University of Medical Sciences, Bahrami Children Hospital, Tehran, Iran
  2. 2. Department of Pediatrics, Tehran University of Medical Sciences, Bahrami Children Hospital, Tehran, Iran
  3. 3. Department of Gastroenterology, Tehran University of Medical Sciences, Bahrami Children Hospital, Tehran, Iran
  4. 4. Young Researchers and Elite Club, Islamic Azad University, Tehran, Iran

Source: Journal of Pediatric and Neonatal Individualized Medicine Published:2021


Abstract

Background: Infantile colic is a disturbing problem for parents. The Rome IV criteria are the last modality for the diagnosis of colic. Available medications have variable effects on the treatment of colic. However, no definite treatment has been identified yet. Aims: To our knowledge, few clinical trials have compared the efficacy of synbiotics in infantile colic, so the present study was conducted. Material and methods: This study was performed on 120 infants (51.66% boys; mean age: 42.09 ± 21.14 days; mean birth weight: 3,155 ± 420 g) with the diagnosis of infantile colic resistant to conservative therapy. The infants were randomly divided into groups A and B. A synbiotic containing B. infantis, L. reuteri, L. rhamnosus, and fructooligosaccharides (FOS) (PediLact® [Zist-Takhmir Co., Tehran, Iran] drop) was administered to group A, while group B received a synbiotic containing B. lactis and FOS (BBCare® [Zist-Takhmir Co., Tehran, Iran] drop). The primary outcome was the response rate to each synbiotic, and the secondary outcome was the complications of each synbiotic. Results: The response rate to both synbiotics was significant after 1 week of intervention (1.97 ± 0.91 [44.95%] versus 1.64 ± 0.77 [54.23%], p = 0.000). Both groups showed a significant response rate to each synbiotic after 1 month of intervention too (1.19 ± 0.84 [63.48%] versus 0.70 ± 0.48 [79.65%], p = 0.000). The response rate was significantly higher in group B compared to group A after 1 week (54.23% versus 44.95%) and after 1 month (79.65% versus 63.48%) of intervention. Neither synbiotic was associated with adverse effects. Conclusion: The present study showed that both synbiotics were effective in the treatment of infantile colic. However, the synbiotic containing B. lactis was significantly more effective than the synbiotic containing B. infantis, L. reuteri, and L. rhamnosus in infantile colic. © 2021. All Rights Reserved.
Related Docs
1. Efficacy of Probiotics for Managing Infantile Colic Due to Their Anti-Inflammatory Properties: A Meta-Analysis and Systematic Review, Clinical and Experimental Pediatrics (2021)
2. Effect of Topical Chamomile Oil (Matricaria Chamomile L.) As a Supplementary Method on Colic Symptoms in Infants: A Randomized Placebo-Controlled Clinical Trial, Iranian Journal of Neonatology (2019)
3. Comparison of the Effect of Massage and Probiotic Consumption on Infantile Colic: A Randomized Clinical Trial, HAYAT (2022)
Experts (# of related papers)
Razieh Sangsari (1)
Mohammad Reza Fazeli (1)